Ray Dalio Ionis Pharmaceuticals Inc Transaction History

Bridgewater Associates, LP

  • $18.9 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
BUY
$31.71 - $43.0 $81,748 - $110,854
2,578 Added 35.8%
9,779 $362,000
Q1 2022

May 13, 2022
BUY
$29.88 - $37.04 $215,165 - $266,725
7,201 New
7,201 $267,000
Q3 2021

Nov 12, 2021
SELL
$33.54 - $40.55 $267,682 - $323,629
-7,981 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$34.54 - $47.25 $275,663 - $377,102
7,981 New
7,981 $318,000

Others Institutions Holding IONS

# of Institutions
389
Shares Held
125M
Call Options Held
2.25M
Put Options Held
510K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email